Healthcare provider profile · identity verified

Jacy Stone

Nurse Practitioner · COON RAPIDS, MN · NPI 1265831317

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	423	36
Metoprolol Succinate	Metoprolol Succinate	386	33
Levothyroxine Sodium	Levothyroxine Sodium	312	31
Gabapentin	Gabapentin	284	28
Atorvastatin Calcium	Atorvastatin Calcium	280	27
Potassium Chloride	Potassium Chloride	274	29
Eliquis	Apixaban	258	20
Sertraline Hcl	Sertraline Hcl	219	18
Lisinopril	Lisinopril	207	17
Amlodipine Besylate	Amlodipine Besylate	203	24
Quetiapine Fumarate	Quetiapine Fumarate	199	18
Omeprazole	Omeprazole	180	19
Mirtazapine	Mirtazapine	174	19
Fluoxetine Hcl	Fluoxetine Hcl	134	12
Pantoprazole Sodium	Pantoprazole Sodium	131	16
Trazodone Hcl	Trazodone Hcl	129	15
Metoprolol Tartrate	Metoprolol Tartrate	126	14
Losartan Potassium	Losartan Potassium	119	12
Rosuvastatin Calcium	Rosuvastatin Calcium	116	12
Famotidine	Famotidine	112	suppressed
Jantoven	Warfarin Sodium	107	suppressed
Memantine Hcl	Memantine Hcl	106	suppressed
Metformin Hcl	Metformin Hcl	106	suppressed
Donepezil Hcl	Donepezil Hcl	104	15
Atenolol	Atenolol	102	suppressed
Carvedilol	Carvedilol	97	suppressed
Loperamide	Loperamide Hcl	97	18
Citalopram Hbr	Citalopram Hydrobromide	89	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	83	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	81	suppressed
Simvastatin	Simvastatin	79	suppressed
Januvia	Sitagliptin Phosphate	77	suppressed
Xarelto	Rivaroxaban	77	suppressed
Nystatin	Nystatin	75	30
Latanoprost	Latanoprost	72	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	70	suppressed
Buspirone Hcl	Buspirone Hcl	65	suppressed
Levetiracetam	Levetiracetam	61	suppressed
Prednisone	Prednisone	57	suppressed
Oxycodone Hcl	Oxycodone Hcl	56	19
Duloxetine Hcl	Duloxetine Hcl	53	suppressed
Trulicity	Dulaglutide	53	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	52	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	50	suppressed
Finasteride	Finasteride	46	suppressed
Tramadol Hcl	Tramadol Hcl	45	13
Quetiapine Fumarate Er	Quetiapine Fumarate	44	suppressed
Spironolactone	Spironolactone	43	suppressed
Torsemide	Torsemide	42	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	41	suppressed
Myrbetriq	Mirabegron	41	suppressed
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Jardiance	Empagliflozin	39	suppressed
Lorazepam	Lorazepam	39	suppressed
Risperidone	Risperidone	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Ibuprofen	Ibuprofen	33	suppressed
Metolazone	Metolazone	32	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	11
Primidone	Primidone	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Cephalexin	Cephalexin	29	18
Alprazolam	Alprazolam	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	suppressed
Albuterol Sulfate	Albuterol Sulfate	23	suppressed
Auvelity	Dextromethorphan Hbr/Bupropion	23	suppressed
Celecoxib	Celecoxib	23	suppressed
Glipizide	Glipizide	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Cefadroxil	Cefadroxil	22	suppressed
Guanfacine Hcl	Guanfacine Hcl	22	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Methimazole	Methimazole	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Baclofen	Baclofen	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Olanzapine	Olanzapine	20	suppressed
Amiloride Hcl	Amiloride Hcl	19	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Sulfasalazine Dr	Sulfasalazine	17	suppressed
Topiramate	Topiramate	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Memantine Hcl Er	Memantine Hcl	16	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Nyamyc	Nystatin	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Indapamide	Indapamide	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Betamethasone Valerate	Betamethasone Valerate	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Enulose	Lactulose	11	suppressed
Gemtesa	Vibegron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error